Improve the appearance of hyperpigmentation safely and effectively

A physician-dispensed cosmetic, Lumixyl™ offers an effective, non-irritating alternative for persons wishing to improve the appearance of dark spots or pigmentation, safely and in the long term.

Developed by dermatological researchers at Stanford University, Lumixyl™’s ground-breaking technology has been shown by in vitro studies to promote a reduction in the expression of melanin, yielding a blended, more even complexion in all skin types.

Lumixyl™ is created for patients seeking more even skin-tone including those with:

• Melasma
• Post-inflammatory hyperpigmentation
• Sun spots, age spots or liver spots
• Photodamage
• Hyperpigmentation caused by systemic disease or prescription drugs

Results without risk

Repeat Insult Patch Tests confirm that, unlike alternative brightening products, Lumixyl™ does not elicit allergic reaction. Furthermore, Lumixyl™ is:

• Non-toxic
• Water-soluble
• Easily Degraded by the skin
• Has no significant cytotoxic effect

Preliminary clincical study results are being evaluated in large confirmatory trials and demonstrate the peptide's ability to yield visible results in improving the appearance of melasma. Study participants included persons who had previously been unsuccessful following six month terms using a hydroquinone, retinol, steroid regimen but reported visible improvements with Lumixyl™ in as little as 8 weeks with a 50% improvement after 16 weeks.

Laboratory proof of mechanism of action shows signifcant molecular action

Lumixyl™ is thought to work by inhibiting tyrosinase, the enzyme responsible for the production of melanin in the skin. In fact, in vitro studies show that Lumixyl™is 5.5 times more effective than hydroquinone at equidosage in the moderation of melanin.